FDA Approval Process Keeps Many Rapid COVID Tests Off Market

Irene Bosch developed a quick, inexpensive COVID-19 test in early 2020. But she was stymied by an FDA process experts say made no sense.

Related Keywords

United States , Germany , United Kingdom , Yale School , Florida , Massachusetts , Brazil , Boston , Cambridge , Cambridgeshire , South Korea , Spain , Venezuela , Britain , Americans , America , Spanish , Brazilian , American , Korea , Irene Bosch , Karthik Dinakar , Vinod Khosla , Yale Paltiel , Jonathan Maa , Jack Feng , Tim Stenzel , Rochelle Walensky , Hannah Mamuszka , David Paltiel , Joshua Sharfstein , Michael Mina , Centers For Disease , National Public Radio , Yale School Of Public Health , National Institutes Of Health , Drug Administration , Melinda Gates Foundation , Abbott Laboratories , Pulitzer Prize Winning , Big Story , National Institutes , Silicon Valley , Anu Khosla , Public Health , Brazilian Amazon , Disease Control , Massachusetts General Hospital , Maxim Biomedical , Complex Interventions , Johns Hopkins University , Bloomberg School ,